The problem with that overview is that it uses data from women. I say thats a problem because Ive read studies on male use of exemestane and arimidex and there seem to be quite wide variances in half life between the sexes (exem=27hrs females, 9hrs men) and differing impacts on lipids.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.